Cargando…

The mevalonate precursor enzyme HMGCS1 is a novel marker and key mediator of cancer stem cell enrichment in luminal and basal models of breast cancer

The definitive characterization of common cancer stem cell (CSCs) subpopulations in breast cancer subtypes with distinct genotypic and phenotypic features remains an ongoing challenge. In this study, we have used a non-biased genome wide screening approach to identify transcriptional networks that m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Walsh, Claire A., Akrap, Nina, Garre, Elena, Magnusson, Ylva, Harrison, Hannah, Andersson, Daniel, Jonasson, Emma, Rafnsdottir, Svanheidur, Choudhry, Hani, Buffa, Francesca, Ragoussis, Jiannis, Ståhlberg, Anders, Harris, Adrian, Landberg, Göran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373278/ https://www.ncbi.nlm.nih.gov/pubmed/32692762 http://dx.doi.org/10.1371/journal.pone.0236187

Ejemplares similares

Sortilin inhibition limits secretion-induced progranulin-dependent breast cancer progression and cancer stem cell expansion
por: Rhost, Sara, et al.
Publicado: (2018)

Tumor co-expression of progranulin and sortilin as a prognostic biomarker in breast cancer
por: Berger, Karoline, et al.
Publicado: (2021)

Mevalonate Pathway Enzyme HMGCS1 Contributes to Gastric Cancer Progression
por: Wang, I-Han, et al.
Publicado: (2020)

Characterization of cell-free breast cancer patient-derived scaffolds using liquid chromatography-mass spectrometry/mass spectrometry data and RNA sequencing data
por: Landberg, Göran, et al.
Publicado: (2020)

Stromal regulation of prostate cancer cell growth by mevalonate pathway enzymes HMGCS1 and HMGCR
por: Ashida, Shingo, et al.
Publicado: (2017)

Antidiabetic drug metformin suppresses tumorigenesis through inhibition of mevalonate pathway enzyme HMGCS1
por: Chen, Yiyan, et al.
Publicado: (2022)

Identification of Distinct Breast Cancer Stem Cell Populations Based on Single-Cell Analyses of Functionally Enriched Stem and Progenitor Pools
por: Akrap, Nina, et al.
Publicado: (2016)

Properties of targeted preamplification in DNA and cDNA quantification
por: Andersson, Daniel, et al.
Publicado: (2015)

Weighted gene co-expression network analysis of colorectal cancer liver metastasis genome sequencing data and screening of anti-metastasis drugs
por: Gao, Bo, et al.
Publicado: (2016)

Debottlenecking mevalonate pathway for antimalarial drug precursor amorphadiene biosynthesis in Yarrowia lipolytica
por: Marsafari, Monireh, et al.
Publicado: (2020)

Hypoxia‐induced secretion stimulates breast cancer stem cell regulatory signalling pathways
por: Jacobsson, Hanna, et al.
Publicado: (2019)

Assessment of Luminal and Basal Phenotypes in Bladder Cancer
por: Guo, Charles C., et al.
Publicado: (2020)

Integrated analysis of microRNA and mRNA expression and association with HIF binding reveals the complexity of microRNA expression regulation under hypoxia
por: Camps, Carme, et al.
Publicado: (2014)

Cell Cycle and Cell Size Dependent Gene Expression Reveals Distinct Subpopulations at Single-Cell Level
por: Dolatabadi, Soheila, et al.
Publicado: (2017)

Mevalonate kinase deficiencies: from mevalonic aciduria to hyperimmunoglobulinemia D syndrome
por: Haas, Dorothea, et al.
Publicado: (2006)

Extensive regulation of the non-coding transcriptome by hypoxia: role of HIF in releasing paused RNApol2
por: Choudhry, Hani, et al.
Publicado: (2014)

Patient-derived scaffolds as a drug-testing platform for endocrine therapies in breast cancer
por: Gustafsson, Anna, et al.
Publicado: (2021)

Idi1 and Hmgcs2 Are Affected by Stretch in HL-1 Atrial Myocytes
por: Fang, Chih-Yuan, et al.
Publicado: (2018)

HMGCS2 Mediates Ketone Production and Regulates the Proliferation and Metastasis of Hepatocellular Carcinoma
por: Wang, Yuan-Hsi, et al.
Publicado: (2019)

Hmgcs2-mediated ketogenesis modulates high-fat diet-induced hepatosteatosis
por: Asif, Shaza, et al.
Publicado: (2022)

Liver HMGCS2 is critical in the maintenance of liver lipid homeostasis during fasting
por: Zhou, Yunfeng, et al.
Publicado: (2022)

Diagnostic value of urinary mevalonic acid excretion in mevalonate kinase deficiency (MKD)
por: Jeyaratnam, Jerold, et al.
Publicado: (2014)

The Effect of Hypoxic and Normoxic Culturing Conditions in Different Breast Cancer 3D Model Systems
por: Svanström, Andreas, et al.
Publicado: (2021)

Inference of tissue relative proportions of the breast epithelial cell types luminal progenitor, basal, and luminal mature
por: Bartlett, Thomas E., et al.
Publicado: (2021)

A multidimensional integration analysis reveals potential bridging targets in the process of colorectal cancer liver metastasis
por: Gao, Bo, et al.
Publicado: (2017)

Recurrent loss of HMGCS2 shows that ketogenesis is not essential for the evolution of large mammalian brains
por: Jebb, David, et al.
Publicado: (2018)

Association of a novel homozygous mutation in the HMGCS2 gene with an HMGCSD in an Iranian patient
por: Heidari, Masoud, et al.
Publicado: (2020)

Breast Cancer Patient-Derived Scaffolds Can Expose Unique Individual Cancer Progressing Properties of the Cancer Microenvironment Associated with Clinical Characteristics
por: Garre, Elena, et al.
Publicado: (2022)

The luminal-basal paradigm in the urothelial cancer: hope for individualized approach
por: Reis, Leonardo Oliveira
Publicado: (2016)

The mevalonate pathway in C. Elegans
por: Rauthan, Manish, et al.
Publicado: (2011)

Mevalonate Metabolism in Immuno-Oncology
por: Gruenbacher, Georg, et al.
Publicado: (2017)

Mevalonate kinase somatic mosaicism and bigenic genotypes may explain heterogeneity in mevalonate kinase deficiency
por: Shinar, Y, et al.
Publicado: (2015)

Identification of Breast Cancer Stem Cell Related Genes Using Functional Cellular Assays Combined With Single-Cell RNA Sequencing in MDA-MB-231 Cells
por: Jonasson, Emma, et al.
Publicado: (2019)

Predictive significance of HMGCS2 for prognosis in resected Chinese esophageal squamous cell carcinoma patients
por: Tang, Hong, et al.
Publicado: (2017)

CircHMGCS1 Promotes Hepatoblastoma Cell Proliferation by Regulating the IGF Signaling Pathway and Glutaminolysis
por: Zhen, Ni, et al.
Publicado: (2019)

Loss of HMGCS2 Enhances Lipogenesis and Attenuates the Protective Effect of the Ketogenic Diet in Liver Cancer
por: Wang, Yuan-Hsi, et al.
Publicado: (2020)

LONP1 targets HMGCS2 to protect mitochondrial function and attenuate chronic kidney disease
por: Bai, Mi, et al.
Publicado: (2023)

HMGCS2 Mediation of Ketone Levels Affects Sorafenib Treatment Efficacy in Liver Cancer Cells
por: Suk, Fat-Moon, et al.
Publicado: (2022)

Hmgcs2 regulates M2 polarization of macrophages to repair myocardial injury induced by sepsis
por: Zou, Xiao-Zheng, et al.
Publicado: (2023)

HMGCS2 serves as a potential biomarker for inhibition of renal clear cell carcinoma growth
por: Mao, Huajie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a3fse3u1n4uruj9akcmtqkiupe